Drug recall D-0521-2016
Product
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98
Reason for recall
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
Lots and codes
Lot #: 24I030, Exp 5/2017
Recall details
- Recalling firm
- Teva Pharmaceutical Industries, Jerusalem, N/A
- Quantity
- 3536 bottles
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 20, 2015
- Terminated
- November 1, 2016
Related products
- Irbesartan and Hydrochlorothiazide – drug information
- NDC 0093-8238 Irbesartan and Hydrochlorothiazide · Irbesartan 150 mg/1; Hydrochlorothiazide 12.5 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-8232 Irbesartan and Hydrochlorothiazide · Irbesartan 300 mg/1; Hydrochlorothiazide 12.5 mg/1 · Teva Pharmaceuticals USA, Inc.